Turnover: 2.5 billion EUR (2022)
Country: Denmark
Gn Hearing has three hearing instrument brands, ReSound GN, Beltone and Interton, with ReSound being the most iconic.
The ReSound brand has its origins in two separate Danish companies. The older of the two is undoubtedly Danavox. This group was founded in 1943 and presented its first hearing aid in 1947. This device used very advanced technology for its time, which allowed Danavox to quickly become the Danish market leader. In 1977 Great Northern, a large Danish telecommunications company, bought Danavox.
ReSound offers a wide range of products, including many different series that differ in the technologies they employ. The hearing instruments in a series are characterised by their shape, colour and the way they can be worn.
Almost all product lines include a Behind-The-Ear (BTE) device, which can be worn behind the ear. This is the most common and usually the most economical solution.
Some ReSound instrument series include in-the-ear (ITE) instruments. These can be placed directly in the ear canal. There are many different versions of ITEs. One of these is the In-the- Canal (IC) model, which is partially placed in the ear canal. An increasing number of clients are choosing CIC (completely in the canal) instruments. These fit completely in the ear canal and are therefore barely visible. On the other hand, ReSound offers a number of CIC models that are not only visually pleasing, but also particularly comfortable.
The LINX series, launched on the market in 2014, has a special significance. This hearing aid is the first to have been awarded the "Made for iPhone" label. It offers the possibility to link the hearing aid directly with one's smartphone and other electronic devices, to contribute to a unique hearing experience.
The group employs 6000 people
Financial Data
DUNS: 509689915
Legal Name: GN HEARING SAS
Address: 19 RUE D ARCUEIL BATIMENT QUEBEC, 94150 RUNGIS
Number of employees: Entre 20 et 49 salariés (2021)
Capital: 2 300 000 EUR
Financial Data:
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|
Turnover | 20 285 759 | 14 348 115 | 20 436 664 | 26 008 290 | 23 671 945 | 24 320 597 | 23 711 919 |
Gross margin (€) | 9 984 202 | 8 727 531 | 9 772 291 | 11 239 426 | 10 800 917 | 11 781 584 | 11 942 334 |
EBITDA (€) | 1 428 800 | 989 612 | 806 737 | 1 356 007 | 1 077 829 | 543 724 | 1 047 028 |
Operating profit (€) | 840 043 | 805 375 | 349 849 | 1 458 629 | 920 416 | 963 097 | 925 407 |
Net profit (€) | 488 906 | 382 002 | 229 554 | 998 843 | 562 653 | 643 051 | 1 066 417 |
Turnover growth rate (%) | 41,4 | -29,8 | -21,4 | 9,9 | -2,7 | 2,6 | - |
Ebitda margin rate (%) | 7 | 6,9 | 3,9 | 5,2 | 4,6 | 2,2 | 4,4 |
Operating margin rate (%) | 4,1 | 5,6 | 1,7 | 5,6 | 3,9 | 4 | 3,9 |
Working Capital (turnover days) | -19,2 | -90,9 | 33,1 | -52,8 | -85,9 | -49,1 | -48,3 |
Working Capital requirements (turnover days) | -10,6 | -93,8 | -23,5 | -11 | -53,5 | -18,5 | -46,1 |
Net margin (%) | 2,4 | 2,7 | 1,1 | 3,8 | 2,4 | 2,6 | 4,5 |
Added value / Turnover (%) | 26,6 | 34 | 24,6 | 20,7 | 20,2 | 10,5 | 21,1 |
Wages and social charges (€) | 3 699 555 | 3 644 445 | 3 973 955 | 3 885 088 | 3 401 249 | 3 458 652 | 3 604 708 |
Salaries / Turnover (%) | 18,2 | 25,4 | 19,4 | 14,9 | 14,4 | 14,2 | 15,2 |
Company Managers:
Position | First Name | Last Name | Age | |
---|---|---|---|---|
Président | Thomas, John | Woods | 58 | |
Directeur général | Xavier, Thierry | Temmos | 46 |
Studies mentioning this company

Other companies mentioned:

Other companies mentioned:
- Sonova
- Sivantos
- Med-el
- Audika
- Demant groupe
- Prodition (Groupe Demant)
- Starkey
- Beltone (GN hearing)
- ReSound (GN Hearing)
- GN Hearing
- Amplifon
- WS Audiology (Widex Sivantos)

Other companies mentioned:
- Oticon
- WS Audiology (Widex Sivantos)
- ReSound (GN Hearing)
- Signia
- Starkey
- Amplifon
- Beltone (GN hearing)
- GN Hearing
- Demant groupe